Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
VYNE Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 132K | $247K | $1.88 | Sep 30, 2024 | Direct |
VYNE Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 62.5K | Jan 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VYNE | VYNE Therapeutics Inc. | Sep 30, 2024 | 1 | -$158 | 4 | Oct 2, 2024 | CHIEF FINANCIAL OFFICER |
VYNE | VYNE Therapeutics Inc. | Jul 1, 2024 | 1 | -$177 | 4 | Jul 3, 2024 | CHIEF FINANCIAL OFFICER |
VYNE | VYNE Therapeutics Inc. | Apr 1, 2024 | 1 | -$290 | 4 | Apr 3, 2024 | CHIEF FINANCIAL OFFICER |
VYNE | VYNE Therapeutics Inc. | Jan 1, 2024 | 3 | -$212 | 4 | Jan 3, 2024 | Chief Financial Officer |
VYNE | VYNE Therapeutics Inc. | Dec 13, 2023 | 2 | $0 | 4 | Dec 15, 2023 | Chief Financial Officer |
VYNE | VYNE Therapeutics Inc. | Oct 2, 2023 | 1 | -$4.16K | 4 | Oct 4, 2023 | Chief Financial Officer |
VYNE | VYNE Therapeutics Inc. | Jun 30, 2023 | 1 | -$373 | 4 | Jul 5, 2023 | Chief Financial Officer |
VYNE | VYNE Therapeutics Inc. | Mar 31, 2023 | 1 | -$1.18K | 4 | Apr 4, 2023 | Chief Financial Officer |
VYNE | VYNE Therapeutics Inc. | Dec 31, 2022 | 1 | -$53 | 4 | Jan 4, 2023 | Chief Financial Officer |
VYNE | VYNE Therapeutics Inc. | Sep 30, 2022 | 1 | -$79 | 4 | Oct 4, 2022 | CFO |
VYNE | VYNE Therapeutics Inc. | Jun 30, 2022 | 1 | -$138 | 4 | Jul 5, 2022 | CFO |
VYNE | VYNE Therapeutics Inc. | May 31, 2022 | 1 | $4.33K | 4 | Jun 2, 2022 | CFO |
VYNE | VYNE Therapeutics Inc. | Mar 31, 2022 | 1 | -$502 | 4 | Apr 4, 2022 | CFO |
VYNE | VYNE Therapeutics Inc. | Mar 17, 2022 | 2 | $0 | 4 | Mar 18, 2022 | CFO |
VYNE | VYNE Therapeutics Inc. | Dec 31, 2021 | 1 | -$210 | 4 | Jan 4, 2022 | Interim CFO |
VYNE | VYNE Therapeutics Inc. | Nov 30, 2021 | 1 | $3.67K | 4 | Dec 2, 2021 | Interim CFO |
VYNE | VYNE Therapeutics Inc. | Sep 30, 2021 | 1 | -$286 | 4 | Oct 1, 2021 | Interim CFO |
VYNE | VYNE Therapeutics Inc. | Sep 2, 2021 | 2 | $0 | 4 | Sep 3, 2021 | Interim CFO |
VYNE | VYNE Therapeutics Inc. | Jun 30, 2021 | 1 | -$2.46K | 4 | Jul 2, 2021 | Interim CFO |
VYNE | VYNE Therapeutics Inc. | Jun 18, 2021 | 0 | $0 | 3 | Jun 21, 2021 | Interim CFO |